APA (7th ed.) Citation

Boulouta, A., Kyriazoglou, A., Economopoulou, P., Kotsantis, I., Kontou, P., Bagos, P., & Psyrri, A. (2025). 3187eP Higher frequency of immune-related adverse events with ICIs in the adjuvant vs metastatic setting. Annals of Oncology, 36, S693. https://doi.org/10.1016/j.annonc.2025.08.1658

Chicago Style (17th ed.) Citation

Boulouta, A., A. Kyriazoglou, P. Economopoulou, I. Kotsantis, P.I Kontou, P.G Bagos, and A. Psyrri. "3187eP Higher Frequency of Immune-related Adverse Events with ICIs in the Adjuvant Vs Metastatic Setting." Annals of Oncology 36 (2025): S693. https://doi.org/10.1016/j.annonc.2025.08.1658.

MLA (9th ed.) Citation

Boulouta, A., et al. "3187eP Higher Frequency of Immune-related Adverse Events with ICIs in the Adjuvant Vs Metastatic Setting." Annals of Oncology, vol. 36, 2025, p. S693, https://doi.org/10.1016/j.annonc.2025.08.1658.